Navigation Links
Aware, Inc. Reports Fourth Quarter and 2007 Financial Results

BEDFORD, Mass., Feb. 12 /PRNewswire-FirstCall/ -- Aware, Inc. (Nasdaq: AWRE), a leading supplier of broadband technology and biometrics software, today reported financial results for its fourth quarter ended December 31, 2007.

Revenues for the fourth quarter of 2007 were $6.8 million, an increase of 5% compared to $6.4 million in the same quarter last year. For the year ended December 31, 2007, revenues increased 10% to $26.4 million, compared to $24.1 million for the year ended December 31, 2006.

The Company reports its net income and basic and diluted net income per share in accordance with U.S. generally accepted accounting principles (GAAP), and additionally, on a non-GAAP basis. Non-GAAP net income, where applicable, excludes the effect of stock-based compensation expense. The company uses the non-GAAP information internally to evaluate its operating performance and believes these non-GAAP measures are useful to investors as they provide additional insight into the underlying operating results. However, non-GAAP measures are not stated in accordance with, should not be considered in isolation from, and are not a substitute for, GAAP measures. A reconciliation of GAAP to non-GAAP results has been provided in the attached financial tables.

GAAP net income for the fourth quarter of 2007 was $0.2 million, or $0.01 per diluted share, which included $0.3 million of stock-based compensation charges in accordance with the provisions of FAS 123(R). This compared to GAAP net income of $0.9 million, or $0.04 per diluted share, for the same period a year ago. GAAP net income for the year ended December 31, 2007 was $0.2 million, or $0.01 per share, compared to net income of $1.0 million, or $0.04 per diluted share, for the year ended December 31, 2006.

Non-GAAP net income for the fourth quarter of 2007, excluding the effect of stock-based compensation, was $0.5 million, or $0.02 per diluted share. For the year ended December 31, 2007, the company had non-GAAP net income, excluding the effect of stock-based compensation, of $1.3 million, or $0.05 per share.

Michael Tzannes, Aware's chief executive officer, said, "Our 2007 results reflect healthy revenue growth in our DSL test and diagnostics hardware and software product lines as well as biometrics software applications. Looking forward to 2008, we are expecting a rebound in our DSL licensing business. Each of these three product lines, DSL test and diagnostics hardware and software, biometrics and medical imaging software and DSL licensing are well positioned for positive revenue and earnings growth."

Note: Aware's conference call will be broadcast live over the Internet today, February 12, 2008 at 5:00 p.m. Eastern Time. To listen to the call, please go to The conference call may also be heard by calling 617-213-4864 and referencing the confirmation number 36075315. A replay of the call will be archived on our website after the call.

About Aware

Aware is a leading technology supplier for the telecommunications industries. For more than ten years, Aware has pioneered innovations at telecommunications standards-setting organizations and continues to develop and market DSL silicon intellectual property and test and diagnostics products. Its StratiPHY(tm) IP product line supports DSL standards, including ADSL2+ and VDSL2, and has been broadly licensed to leading semiconductor companies. Telecom equipment vendors and phone companies use Aware's DSL test and diagnostics modules and Dr. DSL(R) software to help provision DSL circuits globally. Aware is also a veteran of the biometrics industry, providing biometric and imaging software components used in government systems worldwide since 1992. Aware's interoperable, standard-compliant, field-proven imaging products are used in a number of applications, from border management to criminal justice to medical imaging. Aware is a publicly held company (Nasdaq: AWRE) based in Bedford, Massachusetts.

Safe Harbor Warning

Portions of this release contain forward-looking statements regarding future events and are subject to risks and uncertainties, such as estimates or projections of future revenue and earnings and the growth of the DSL and biometrics markets. Aware wishes to caution you that there are factors that could cause actual results to differ materially from the results indicated by such statements. The DSL factors include, but are not limited to: we have a unique business model, our quarterly results are difficult to predict, we depend on a limited number of licensees, we derive a significant amount of revenue from a small number of customers, we depend on equipment companies to incorporate our technology into their products, we face intense competition from other DSL vendors, DSL technology competes with other technologies for broadband access, and our business is subject to rapid technological change. The biometric factors include, but are not limited to: market acceptance of our biometric products, changes in contracting practices of government or law enforcement agencies, announcements or introductions of new products by our competitors, delays, failures or problems in our biometric products, delays in the adoption of new industry biometric standards, and competitive pressures resulting in lower software product revenues. We refer you to the documents Aware files from time to time with the Securities and Exchange Commission, specifically the section titled Risk Factors in our annual report on Form 10-K for the fiscal year ended December 31, 2006 and other reports and filings made with the Securities and Exchange Commission.

Aware, StratiPHY, and Dr. DSL are trademarks or registered trademarks of Aware, Inc.



(In thousands, except per share data)


Three Months Ended Year Ended

December 31, December 31,

2007 2006 2007 2006


Product sales $5,158 $2,637 $17,491 $7,610

Contract revenue 1,077 2,644 6,337 12,569

Royalties 518 1,168 2,609 3,877

Total Revenue 6,753 6,449 26,437 24,056

Costs and expenses:

Cost of product sales(1) 912 303 3,998 918

Cost of contract revenue(1) 1,110 1,422 5,425 5,182

Research and development(1) 3,134 2,391 10,869 10,591

Selling and marketing(1) 930 841 3,738 3,359

General and administrative(1) 967 1,030 4,237 4,405

Total costs and expenses 7,053 5,987 28,267 24,455

Net income (loss) from

operations (300) 462 (1,830) (399)

Interest income 496 498 2,016 1,840

Net income before provision

for income taxes 196 960 186 1,441

Provision for income taxes (3) (77) (26) (407)

Net income $193 $883 $160 $1,034

Net income per share - basic $0.01 $0.04 $0.01 $0.04

Net income per share - diluted $0.01 $0.04 $0.01 $0.04

Weighted average shares -

basic 23,818,467 23,596,832 23,737,715 23,474,048

Weighted average shares -

diluted 24,917,360 24,998,093 25,083,700 24,964,958

(1) Effective January 1, 2006 the Company adopted Statement of Financial

Accounting Standard No. 123 (Revised), "Share-Based Payment"

(FAS 123(R)). The amounts in the tables above include stock-based

compensation as follows (in thousands):

Three Months Ended Year Ended

December 31, December 31,

2007 2006 2007 2006

Cost of product sales $5 $3 $13 $15

Cost of contract revenue 43 51 176 149

Research and development 172 118 483 904

Sales and marketing 41 23 119 289

General and administrative 85 48 347 580

Total stock-based compensation

costs $346 $243 $1,138 $1,937


Non-GAAP Financial Measures and Reconciliation

(In thousands, except per share data)


Three Months Ended Year Ended

December 31, December 31,

2007 2006 2007 2006

GAAP net income $193 $882 $160 $1,034

Stock-based compensation 346 243 1,138 1,937

Non-GAAP net income $539 $1,125 $1,298 $2,971

Three Months Ended Year Ended

December 31, December 31,

2007 2006 2007 2006

GAAP diluted net income per share $0.01 $0.04 $0.01 $0.04

Stock-based compensation per share 0.01 0.01 0.04 0.08

Non-GAAP diluted net income per share $0.02 $0.05 $0.05 $0.12



(In thousands)


December 31, December 31,

2007 2006


Cash and investments $38,549 $39,802

Accounts receivable, net 7,661 4,738

Inventories, net 1,424 819

Property and equipment, net 7,872 8,123

Other assets, net 877 1,104

Total assets $56,383 $54,586


Total current liabilities $2,817 $2,886

Long-term deferred revenue 330 330

Total stockholders' equity 53,236 51,370

Total liabilities and stockholders' equity $56,383 $54,586

SOURCE Aware, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology news :

1. Aware, Inc. Announces Richard Moberg to Return as CFO
2. Aware, Inc. Introduces Biometrics Software for Tenprint Autocapture
3. MIT reports new twist in microRNA biology
4. Drug aimed at 2 bioterror agents blocks live viral infection, Weill Cornell team reports
5. UVA reports surprising findings related to myotonic muscular dystrophy
6. Rong Li Lab reports protein interactions of MAP kinase signaling pathway
7. WHRC releases 4 key reports
8. BIO-key Reports Third Quarter 2007 Results
9. Emory paleontologist reports discovery of carnivorous dinosaur tracks in Australia
10. Communication Intelligence Corporation Reports Second Quarter 2007 Financial Results
11. BIO-key Reports Second Quarter 2007 Results
Post Your Comments:
(Date:10/29/2015)... Oct. 29, 2015  The J. Craig Venter Institute ... "DNA Synthesis and Biosecurity: Lessons Learned and Options for ... Health and Human Services guidance for synthetic biology providers ... --> --> Synthetic ... the potential to pose unique biosecurity threats. It now ...
(Date:10/29/2015)... Oct. 29, 2015 Today, LifeBEAM ... partnership with 2XU, a global leader in technical ... smart hat with advanced bio-sensing technology. The hat ... to monitor key biometrics to improve overall training ... the two companies will bring together the most advanced ...
(Date:10/26/2015)... and LAS VEGAS , Oct. ... Labs , an innovator in modern authentication and a ... announced the launch of its latest version of the ... enabling organizations to use standards-based authentication that supports existing ... S3 Authentication Suite is ideal for organizations deploying customer-facing ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... ... November 25, 2015 , ... ... were featured on AngelList early in their initial angel funding process. Now, they ... for individuals looking to make early stage investments in the microbiome space. ...
(Date:11/24/2015)... , Nov. 24, 2015 /CNW/ - iCo Therapeutics ... today reported financial results for the quarter ended ... expressed in Canadian dollars and presented under International ... United States ," said Andrew Rae ... advancements regarding iCo-008 are not only value enriching ...
(Date:11/24/2015)... 2015 --> ... "Oligonucleotide Synthesis Market by Product & Services (Primer, Probe, ... DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) ... market is expected to reach USD 1,918.6 Million by ... CAGR of 10.1% during the forecast period. ...
(Date:11/24/2015)... Israel , Nov. 24, 2015  Tikcro Technologies Ltd. (OTCQB: TIKRF) ... on December 29, 2015 at 11:00 a.m. Israel ... Electra Tower, 98 Yigal Allon Street, 36 th Floor, ... of Eric Paneth and Izhak Tamir to the ... Rami Skaliter as external directors; , approval of an amendment to ...
Breaking Biology Technology: